Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06651645 · ClinicalTrials.gov registry record
Pre- vs Post-Pandemic Risk-adjusted Survival Rates in the US Hospitals
A clinical trial of In-hospital Mortality and Non-COVID Deaths, sponsored by National Institutes of Health Clinical Center (CC).
- Active
- Registry status
- 30,000,000
- Enrollment target
- 1
- Study location
NCT06651645: Active study of In-hospital Mortality and Non-COVID Deaths, sponsored by National Institutes of Health Clinical Center (CC).
NCT06651645 is a study of In-hospital Mortality and Non-COVID Deaths that is active but no longer recruiting, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 30,000,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06651645, a study of In-hospital Mortality and Non-COVID Deaths, is active but no longer recruiting, sponsored by National Institutes of Health Clinical Center (CC).
- ACTIVE NOT RECRUITING
- Registry status
- 30,000,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to perform a retrospective cohort study of administrative health data to understand how care delivery performance varies across US hospitals post-COVID-19 pandemic compared to the pre-pandemic performance. We also hope to identify which factors contribute to performance changes.
Primary Outcome
Our primary outcome will be based on a composite measure of in-hospital mortality or discharge to hospice as determined by discharge status code. The primary outcome will itself be expressed as a modified standardized mortality ration (mSMR) calculated as mean-shrunken number of observed deaths or discharge to hospice divided by the expected number of deaths or discharge to hospice for a center in that post-pandemic month assuming the effects of a typical center in the pre-pandemic era.
Conditions Studied
Interventions
- OTHER COVID-19 Surge
Study Locations (1)
Maryland
- National Institutes of Health - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000,000 participants |
| Start Date | 2024-07-30 |
| Est. Completion | 2025-06-30 |
What the registry record for NCT06651645 still lists
NCT06651645 is an observational study that tracks outcomes without assigning an intervention. Its 30,000,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 3 conditions, with In-hospital Mortality appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 Surge is the first listed.
NCT06651645 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06651645 about?
NCT06651645 is a clinical study titled "Pre- vs Post-Pandemic Risk-adjusted Survival Rates in the US Hospitals". This study aims to perform a retrospective cohort study of administrative health data to understand how care delivery performance varies across US hospitals post-COVID-19 pandemic compared to the pre-pandemic performance. We also hope to identify which factors contribute to performance changes.
What is the current status of trial NCT06651645?
This trial is currently active not recruiting. The enrollment target is 30,000,000 participants. The study started on 2024-07-30. Estimated completion is 2025-06-30.
What conditions does trial NCT06651645 study?
This clinical trial studies the following conditions: In-hospital Mortality, Non-COVID Deaths, Surge.
What interventions are being tested in trial NCT06651645?
The interventions under investigation include: COVID-19 Surge (OTHER).
Who is sponsoring clinical trial NCT06651645?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06651645 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02485847 · 20,000,000 participants
IRIS Registry: Intelligent Research in Sight Registry
- NCT05678699 · 10,000,000 participants · NA
The Effects of Medicaid Policy Interventions on Racial Equity in Severe Maternal Morbidity
- NCT02693223 · 3,892,063 participants
Get With the Guidelines-Stroke Registry
- NCT06803498 · 3,000,000 participants
Delivery Room Intervention and Evaluation Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI